Paytm to lend Rs 743 crore to two Vijay Shekhar Sharma companies : Bulletin: Business Today
Business Today
Loading...
 

Paytm to lend Rs 743 crore to two Vijay Shekhar Sharma companies

Loading the player...

Rashi Bisaria | June 7, 2021

COVID-19 Delta variant, first identified in India, 40% more transmissible: UK Health Minister

The Delta variant of coronavirus, or the B1.617.2 variant first identified in India, is about 40 per cent more transmissible than the Alpha or so-called Kent variant of concern, making unlocking plans set for June 21 more difficult, UK Health Secretary Matt Hancock said on Sunday. Hancock attributed the recent rise in coronavirus infections in the country to the spread of Delta variant.

CoronaVac COVID-19 vaccine for children above 3 years approved in China

China has authorised the emergency use of CoronaVac, a COVID-19 vaccine manufactured by Chinese firm Sinovac, for children aged between 3 and 17 years, Sinovac Chairman Yin Weidong said. Sinovac has finished the Phase I and II clinical research stage, involving several hundred volunteers in this age group, which has proved that the vaccine is as safe and efficient as it is for adults

UK PM Boris Johnson urges G7 to vaccinate world by end of 2022

British Prime Minister Boris Johnson on Saturday called for leaders of the Group of Seven (G7) rich nations to make a commitment to vaccinate the entire world against COVID-19 by the end of 2022 when they meet in Britain next week. Johnson will host the first in-person summit in almost two years of G7 leaders.

Paytm to lend Rs 743 crore to two Vijay Shekhar Sharma companies ahead of IPO

One97 Communications Ltd, parent company of online payments app Paytm is set to extend Rs 743 crore funding to two companies owned by founder Vijay Shekhar Sharma. This development comes ahead of the $3 billion IPO planned later this year. The proposal will be put to vote at the company's annual meeting on June 30.

G7 deal for minimum 15% global corporate tax to benefit India: Experts

The historic pact inked by G7, a group of the world's richest nations, to back a minimum global corporation tax rate of at least 15 per cent will benefit India as the effective domestic tax rate is above the threshold, and the country would continue to attract investment, as per tax experts. The Group of Seven on Saturday reached a landmark deal to close cross-border tax loopholes used by some of the world's biggest companies

New drug for COVID-19 treatment? CSIR, Laxai Life begin phase II trials for Niclosamide

The Council of Scientific and Industrial Research (CSIR), in collaboration with Hyderabad-based Laxai Life Sciences Pvt Ltd, has initiated phase II clinical trials of anti-helminitic drug Niclosamide for treatment of COVID-19. Niclosamide has been extensively used in the past for treatment of tapeworm infection in adults as well as children.

More from this section